9 结果
The Decompressive Craniectomy In MALignant middle cerebral artery infarction (DECIMAL) trial is a prospective, multicenter, randomized, open (single blind for the evaluation of the primary outcome measure) controlled study of the efficacy of decompressive craniectomy plus the standard medical
Main objective / secondary
The objectives are:
- To assess frequency of cortical infarcts in the cohort of patients recruited consecutively likely AAFC GHPSJ since 2007
- To assess the link between the presence of myocardial infarction and the clinical characteristics of patients and
- To study the
Acute intestinal ischemic injury (i3), or intestinal infarction, is an extremely severe condition that affects the intestine, with a mortality rate that is over 80%, and with major anatomical and functional consequences for the surviving patients, mainly because of intestinal resections, which are
This study will be conducted in Nuclear Medicine departments (Nancy Hospital, Bichat Hospital in Paris, Pasteur private hospital in Toulouse), with D.SPECT camera (Cyclopharma). The D.SPECT camera recording will be realized following the conventional camera recording and will not modify the routine
The aim of PARTAGE study (Predictive values of blood pressure and arterial stiffness in institutionalized very aged population) is to determine the predictive value of blood pressure (BP) and arterial stiffness estimated by pulse wave velocity (PWV) on overall mortality, major CV events and
The risk of thrombotic complications after implantation of drug-eluting stents (DES) in coronary arteries may be increased in patients with diabetes mellitus (DM) or metabolic syndrome (MS). It is recommended that all patients take an association of aspirin and clopidogrel for several months after
1. INTRODUCTION
The RUDI FREE REGISTRY on the polymer-free DES (BIOFREEDOM) for coronary artery disease is a investigator-initiated, prospective, multicenter registry of all-comers patients with an indication to percutaneous coronary intervention. This Registry will enroll 1000 patients in
Background The ability to control a patient's body temperature under a wide variety of conditions is extremely important, and is of particular importance after CA. TH targeted to 32-34°C as a targeted temperature management (TTM) demonstrably improves outcomes in at least two clinical conditions: